Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01822496
Brief Title: Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

First Submitted : April 1, 2013
First Submitted that Met QC Criteria : April 1, 2013
First Posted : April 2, 2013 (Estimate)

Results First Submitted : June 19, 2019
Results First Submitted that Met QC Criteria : August 2, 2019
Results First Posted : August 5, 2019

Last Update Submitted that Met QC Criteria : August 2, 2019
Last Update Posted : August 5, 2019